APA (7th ed.) Citation

Murali, A., A, A. F., Subramaniam, S., Eapen, M., Nair, I. R., & Pavithran, K. (2024, September). Exceptional long term response to crizotinib in ROS 1‐postive advanced non small cell lung cancer. Respirology Case Reports.

Chicago Style (17th ed.) Citation

Murali, Anjali, Anju Farsana A, Sobha Subramaniam, Malini Eapen, Indu R. Nair, and Keechilat Pavithran. "Exceptional Long Term Response to Crizotinib in ROS 1‐postive Advanced Non Small Cell Lung Cancer." Respirology Case Reports Sep. 2024.

MLA (9th ed.) Citation

Murali, Anjali, et al. "Exceptional Long Term Response to Crizotinib in ROS 1‐postive Advanced Non Small Cell Lung Cancer." Respirology Case Reports, Sep. 2024.